SCM Strengthens US Presence
UK-based sterile manufacturing specialist SCM Pharma has bolstered its North American profile with the appointment of a US-based business development manager.
Derek Richards will oversee the contract development and manufacturing organisation’s (CDMO) business development activities across the territory and will be responsible for growing its overall US footprint.
Previously of Aptuit, Novartis and Schering Plough, Derek brings an impressive track record in sterile fill finish and formulation development to his new role.
The move comes just weeks after SCM Pharma’s UK-based clinical development and manufacturing facility was approved at the first attempt by FDA.
The inspection was triggered by the company supporting British specialist healthcare company BTG in preparation for the commercial launch of Varithena (polidocanol injectable foam), after providing clinical development consultancy for the product for several years.
Dianne Sharp, managing director at SCM Pharma, said: “The minute we knew FDA were due to inspect our clinical headquarters in Prudhoe, we recognised the need to strengthen our US presence as the approval will no doubt trigger more demand for our small-scale clinical and contract manufacturing services in North America.
“As soon as Derek came on our radar, we knew he was the ideal person for this role. His experience and expertise in the sterile and clinical manufacturing area is a perfect fit for our business and his energy will help us realise our ambitions to expand our client-base in the US.
“We already work with big pharma and charitable organisations in the US on clinical development projects and we expect our low volume ampoule and vial filling services will be of interest to many companies looking to run trials or supply products in Europe,” added Dianne.
The award-winning SCM Pharma already works with several companies in the US and has built its reputation around the sterile filling of novel products, difficult processes and applications and dangerous substances such as potent products requiring high containment.
An experienced commercial executive, Derek has worked across the pharmaceutical sector for around 20 years and will head-up the CDMO’s US sales operations from the East Coast.
He said: “I first became aware of SCM Pharma from conversations at a Parenteral Drug Association meeting and began to hear more about their capabilities and expertise in the sterile filling area.
“I was immediately attracted to the company as it has a real entrepreneurial spirit and can do attitude culture backed up by industry leading technical expertise and strong quality systems.
“My aim is to bring US pharmaceutical and biotech firms to this highly flexibility UK-based contract manufacturer that over delivers on its commitments. I am very excited to be an integral part of SCM’s US growth strategy and look forward to helping the business meet its commercial objectives.”
SCM Pharma’s FDA approval topped off a milestone year for the company after gaining an MHRA licence for its new commercial manufacturing facility last summer, which complements its clinical manufacturing facility nearby.
Independently-owned, most of its clients’ projects involve the aseptic filling and terminal sterilisation of liquids and powders into vials, ampoules and syringes.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance